Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
B 3.62 -8.12% -0.32
MYO closed down 8.12 percent on Tuesday, May 7, 2024, on 74 percent of normal volume.
Earnings due: May 8
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up

Date Alert Name Type % Chg
Slingshot Bullish Bullish Swing Setup 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Stochastic Sell Signal Bearish -8.12%
Pocket Pivot Bullish Swing Setup -8.12%
Volume Surge Other -8.12%
Wide Range Bar Range Expansion -8.12%
Upper Bollinger Band Walk Strength -8.12%
Wide Bands Range Expansion -8.12%
Overbought Stochastic Strength -8.12%

   Recent Intraday Alerts

Alert Time
10 DMA Support about 19 hours ago
Down 1 ATR about 19 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 5% about 21 hours ago
60 Minute Opening Range Breakdown about 23 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myomo Inc. Description

Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Organ Systems Disability Robotics Neurological Disorders Stroke Multiple Sclerosis Amyotrophic Lateral Sclerosis Prosthetics Nerve Urological Disorders Orthopedics Podiatry Spinal Cord Skeletal System Neurotrauma

Is MYO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.5799
52 Week Low 0.371
Average Volume 280,795
200-Day Moving Average 2.60
50-Day Moving Average 3.37
20-Day Moving Average 3.30
10-Day Moving Average 3.57
Average True Range 0.32
RSI (14) 54.95
ADX 17.63
+DI 32.54
-DI 16.39
Chandelier Exit (Long, 3 ATRs) 3.41
Chandelier Exit (Short, 3 ATRs) 3.48
Upper Bollinger Bands 4.03
Lower Bollinger Band 2.58
Percent B (%b) 0.72
BandWidth 44.04
MACD Line 0.14
MACD Signal Line 0.06
MACD Histogram 0.07
Fundamentals Value
Market Cap 100.89 Million
Num Shares 27.9 Million
EPS -0.49
Price-to-Earnings (P/E) Ratio -7.39
Price-to-Sales 5.49
Price-to-Book 9.30
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.21
Resistance 3 (R3) 4.25 4.09 4.11
Resistance 2 (R2) 4.09 3.94 4.07 4.07
Resistance 1 (R1) 3.86 3.85 3.78 3.82 4.04
Pivot Point 3.70 3.70 3.67 3.68 3.70
Support 1 (S1) 3.47 3.55 3.39 3.43 3.20
Support 2 (S2) 3.31 3.46 3.29 3.17
Support 3 (S3) 3.08 3.31 3.13
Support 4 (S4) 3.04